Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.725 USD | +2.78% | -54.55% | -69.04% |
Apr. 30 | Canaccord Genuity Cuts Price Target on Annovis Bio to $26 From $36, Maintains Buy Rating | MT |
Apr. 29 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- MarketScreener Editorial Features